Works matching DE "LUTEINIZING hormone releasing hormone agonists"

Results: 248

Important Considerations in LHRH Antagonist Therapy for Prostate Cancer.

Published in:

Oncology (08909091), 2009, v. 23, n. 7, p. 636

By:

Garnick, Marc B.

Publication type:

Article

Is There a Role for LHRH Antagonists in Prostate Cancer?

Published in:

Oncology (08909091), 2009, v. 23, n. 7, p. 632

By:

Goodman, Oscar B.

Publication type:

Article

LHRH Antagonists vs LHRH Agonists: Which Is More Beneficial in Prostate Cancer Therapy?

Published in:

Oncology (08909091), 2009, v. 23, n. 7, p. 631

By:

Keizman, Daniel;
Eisenberger, Mario A.

Publication type:

Article

Ovarian hyperstimulation syndrome following GnRH agonist trigger-think ectopic.

Published in:

Journal of Assisted Reproduction & Genetics, 2017, v. 34, n. 9, p. 1161, doi. 10.1007/s10815-017-0960-0

By:

Orvieto, Raoul;
Vanni, Valeria

Publication type:

Article

Triggering final follicular maturation: hCG, GnRH-agonist, or both, when and to whom?

Published in:

2017

By:

Orvieto, Raoul

Publication type:

Letter

The benefits of dual and double ovulatory triggers in assisted reproduction.

Published in:

2017

By:

Elias, Rony;
Pereira, Nigel;
Palermo, Gianpiero

Publication type:

Letter

Combined GnRH-agonist and human chorionic gonadotropin trigger improves ICSI cycle outcomes in patients with history of poor fertilization.

Published in:

Journal of Assisted Reproduction & Genetics, 2017, v. 34, n. 6, p. 781, doi. 10.1007/s10815-017-0917-3

By:

Elias, Rony;
Pereira, Nigel;
Artusa, Lisa;
Kelly, Amelia;
Pasternak, Monica;
Lekovich, Jovana;
Palermo, Gianpiero;
Rosenwaks, Zev

Publication type:

Article

GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone.

Published in:

Journal of Assisted Reproduction & Genetics, 2016, v. 33, n. 9, p. 1175, doi. 10.1007/s10815-016-0755-8

By:

O'Neill, Kathleen;
Senapati, Suneeta;
Maina, Ivy;
Gracia, Clarisa;
Dokras, Anuja

Publication type:

Article

Failure of GnRH agonist-triggered oocyte maturation: its cause and management.

Published in:

2013

By:

Asada, Yoshimasa;
Itoi, Fumiaki;
Honnma, Hiroyuki;
Takiguchi, Shuji;
Fukunaga, Noritaka;
Hashiba, Yoshiki;
Baba, Tsuyoshi;
Endo, Toshiaki

Publication type:

Report

Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization.

Published in:

Journal of Assisted Reproduction & Genetics, 2012, v. 29, n. 3, p. 225, doi. 10.1007/s10815-011-9685-7

By:

Chang, Eun;
Han, Ji;
Won, Hyung;
Kim, You;
Yoon, Tae;
Lee, Woo

Publication type:

Article

Application of GnRH antagonist in combination with clomiphene citrate and hMG for patients with exaggerated ovarian response in previous IVF/ICSI cycles.

Published in:

Journal of Assisted Reproduction & Genetics, 2007, v. 24, n. 8, p. 331, doi. 10.1007/s10815-007-9127-8

By:

Yu-Hung Lin;
Kok-Min Seow;
Bih-Chwen Hsieh;
Lee-Wen Huang;
Heng-Ju Chen;
Shih-Chia Huang;
Chih-Yu Chen;
Pei-Hsin Chen;
Jiann-Loung Hwang;
Chi-Ruey Tzeng

Publication type:

Article

Single and Repeated GnRH Agonist Stimulation Tests Compared With Basal Markers of Ovarian Reserve in the Prediction of Outcome in IVF.

Published in:

Journal of Assisted Reproduction & Genetics, 2005, v. 22, n. 2, p. 65, doi. 10.1007/s10815-005-1495-3

By:

Hendriks, D. J.;
Broekmans, F. J.;
Bancsi, L. F. J. M. M.;
Looman, C. W. N.;
De Jong, F. H.;
te Velde, E. R.

Publication type:

Article

Final follicular maturation by administration of GnRH agonist plus HCG versus HCG in normal responders in ART cycles: An RCT.

Published in:

International Journal of Reproductive Biomedicine, 2017, v. 15, n. 7, p. 429

By:

Eftekhar, Maryam;
Mojtahedi, Maryam Farid;
Miraj, Sepideh;
Omid, Malihe

Publication type:

Article

Partial androgen suppression consequent to increased secretion of adrenal androgens in a patient with prostate cancer treated with long-acting GnRH agonists.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 100, doi. 10.1038/pcan.2008.15

By:

Spitz, I. M.;
Chertin, B.;
Fridmans, A.;
Farkas, A.;
Belanger, A.;
Hartman, H.;
Labrie, F.

Publication type:

Article

Bicalutamide 80 mg combined with a luteinizing hormone-releasing hormone agonist (LHRH-A) versus LHRH-A monotherapy in advanced prostate cancer: findings from a phase III randomized, double-blind, multicenter trial in Japanese patients.

Published in:

Prostate Cancer & Prostatic Diseases, 2007, v. 10, n. 2, p. 194, doi. 10.1038/sj.pcan.4500934

By:

Usami, M.;
Akaza, H.;
Arai, Y.;
Hirano, Y.;
Kagawa, S.;
Kanetake, H.;
Naito, S.;
Sumiyoshi, Y.;
Takimoto, Y.;
Terai, A.;
Yoshida, H.;
Ohashi, Y.

Publication type:

Article

Evaluating the use of early hormonal therapy in patients with localised or locally advanced prostate cancer.

Published in:

Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 140, doi. 10.1038/sj.pcan.4500800

By:

Kaisary, A. V.

Publication type:

Article

Menstrual cycle pattern during the first gynaecological years in girls with precocious puberty following gonadotropin-releasing hormone analogue treatment.

Published in:

2007

By:

Arrigo, Teresa;
De Luca, Filippo;
Antoniazzi, Franco;
Galluzzi, Fiorella;
Iughetti, Lorenzo;
Pasquino, Anna Maria;
Salerno, Maria Carolina;
Marseglia, Lucia;
Crisafulli, Giuseppe

Publication type:

journal article

GnRH agonist long protocol versus GnRH antagonist protocol for various aged patients with diminished ovarian reserve: A retrospective study.

Published in:

PLoS ONE, 2018, v. 13, n. 11, p. 1, doi. 10.1371/journal.pone.0207081

By:

Huang, Ming-Chao;
Tzeng, Shu-Ling;
Lee, Chun-I;
Chen, Hsiu-Hui;
Huang, Chun-Chia;
Lee, Tsung-Hsien;
Lee, Maw-Sheng

Publication type:

Article

Mini-dose long gonadotropin-releasing hormone (GnRH) agonist versus agonist flare stimulation protocol for in vitro fertilization poor responders.

Published in:

Middle East Fertility Society Journal, 2014, v. 19, n. 4, p. 287, doi. 10.1016/j.mefs.2013.10.001

By:

Shaban, Mona Mohamed

Publication type:

Article

Pregnancy rate after ovulation triggering with gonadotrophin releasing hormone agonist versus human chorionic gonadotrophin in women undergoing controlled ovarian stimulation/intrauterine insemination.

Published in:

Middle East Fertility Society Journal, 2014, v. 19, n. 4, p. 262, doi. 10.1016/j.mefs.2013.08.002

By:

Soliman, Badeea S.;
Siam, Soha

Publication type:

Article

Pemfigoid pęcherzowy rozwinięty po zaprzestaniu leczenia hormonalnego z powodu raka prostaty.

Published in:

Clinical Dermatology / Dermatologia Kliniczna, 2011, v. 13, n. 1, p. 19

By:

Budzińska, Aleksandra;
Gornowicz, Justyna;
Bowszyc-Dmochowska, Monika;
Dmochowski, Marian

Publication type:

Article

Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages.

Published in:

Reproductive Biology & Endocrinology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12958-015-0075-3

By:

Yan Huang;
En-yin Wang;
Qing-yun Du;
Yu-jing Xiong;
Xiao-yi Guo;
Yi-ping Yu;
Ying-pu Sun

Publication type:

Article

Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.

Published in:

Reproductive Biology & Endocrinology, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1477-7827-11-16

By:

Xiaoyan Li;
Xiang Kang;
Qingchun Deng;
Jing Cai;
Zehua Wang

Publication type:

Article

Transperineal prostate brachytherapy, using I-125 seed with or without adjuvant androgen deprivation, in patients with intermediate-riskprostate cancer: study protocol for a phase III, multicenter, randomized, controlled trial.

Published in:

BMC Cancer, 2010, v. 10, p. 572, doi. 10.1186/1471-2407-10-572

By:

Miki, Kenta;
Kiba, Takayoshi;
Sasaki, Hiroshi;
Kido, Masahito;
Aoki, Manabu;
Takahashi, Hiroyuki;
Miyakoda, Keiko;
Dokiya, Takushi;
Yamanaka, Hidetoshi;
Fukushima, Masanori;
Egawa, Shin

Publication type:

Article

NewsUpdate.

Published in:: Urology Times, 2010, v. 38, n. 7, p. 8
Publication type:: Article

Lower payment not only factor in dropping LHRH usage.

Published in:

Urology Times, 2009, v. 37, n. 9, p. 35

By:

Overmyer, Mac

Publication type:

Article

Study documents health risks of GnRH therapy.

Published in:

Urology Times, 2006, v. 34, n. 14, p. 6

By:

Guttman, Cheryl

Publication type:

Article

Antiandrogen plus LHRHa efficacious in advanced PCa.

Published in:

Urology Times, 2005, v. 33, n. 11, p. 10

By:

Nierengarten, Mary Beth

Publication type:

Article

Reimbursement cuts: Urologists prepare for the worst.

Published in:: Urology Times, 2004, v. 32, n. 14, p. 32
Publication type:: Article

GnRH agonists confer increased risk of fractures.

Published in:

Urology Times, 2004, v. 32, n. 14, p. 20

By:

Lorio, Angela

Publication type:

Article

Urologists may be targeted in second LHRH case.

Published in:: Urology Times, 2003, v. 31, n. 8, p. 1
Publication type:: Article

AHCPR: LHRH agonists are equally effective.

Published in:: Urology Times, 1999, v. 27, n. 3, p. 3
Publication type:: Article

Medical approach may solve priapism problem for sickle-cell boys.

Published in:

Urology Times, 1997, v. 25, n. 2, p. 6

By:

Scheck, Anne

Publication type:

Article

Cognitive impairment in men treated with luteinizing hormone-releasing hormone agonists for prostate cancer: a controlled comparison.

Published in:

Supportive Care in Cancer, 2010, v. 18, n. 1, p. 21, doi. 10.1007/s00520-009-0625-3

By:

Jim, Heather S. L.;
Small, Brent J.;
Patterson, Stephen;
Salup, Raoul;
Jacobsen, Paul B.

Publication type:

Article

G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival.

Published in:

Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 12, p. 3175, doi. 10.1007/s00432-020-03333-4

By:

Schüler-Toprak, Susanne;
Skrzypczak, Maciej;
Ignatov, Tanja;
Ignatov, Atanas;
Ortmann, Olaf;
Treeck, Oliver

Publication type:

Article

Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study.

Published in:

Journal of Cancer Research & Clinical Oncology, 2008, v. 134, n. 12, p. 1385, doi. 10.1007/s00432-008-0409-z

By:

Arai, Yoichi;
Akaza, Hideyuki;
Deguchi, Takashi;
Fujisawa, Masato;
Hayashi, Mikio;
Hirao, Yoshihiko;
Kanetake, Hiroshi;
Naito, Seiji;
Namiki, Mikio;
Tachibana, Masaaki;
Usami, Michiyuki;
Ohashi, Yasuo

Publication type:

Article

IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1305, doi. 10.1007/s00262-020-02749-8

By:

Van der Meer, J. M. R.;
Maas, R. J. A.;
Guldevall, K.;
Klarenaar, K.;
de Jonge, P. K. J. D.;
Evert, J. S. Hoogstad-van;
van der Waart, A. B.;
Cany, J.;
Safrit, J. T.;
Lee, J. H.;
Wagena, E.;
Friedl, P.;
Önfelt, B.;
Massuger, L. F.;
Schaap, N. P. M.;
Jansen, J. H.;
Hobo, W.;
Dolstra, H.

Publication type:

Article

Controverse: utilité des agonistes de la GnRH en protection ovarienne en cours de chimiothérapie pour cancer du sein.

Published in:

Oncologie (Tech Science Press), 2012, v. 14, n. 6/7, p. 386, doi. 10.1007/s10269-012-2176-3

By:

Rousset-Jablonski, C.;
Dagousset, I.

Publication type:

Article

Reply: GnRH antagonists vs. long GnRH agonists in IVF: significant flaws in a meta-analysis lead to invalid conclusions.

Published in:

2018

By:

Lambalk, C. B.;
Banga, F. R.;
Huirne, J. A.;
Toftager, M.;
Pinborg, A.;
Homburg, R.;
Van der Veen, F.;
Van Wely, M.

Publication type:

journal article

GnRH antagonists vs. long GnRH agonists in IVF: significant flaws in a meta-analysis lead to invalid conclusions.

Published in:

2018

By:

Kolibianakis, Efstratios M.;
Griesinger, Georg;
Venetis, Christos A.

Publication type:

journal article

Reply: GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data.

Published in:

Human Reproduction Update, 2012, v. 18, n. 2, p. 229, doi. 10.1093/humupd/dmr056

By:

Humaidan, P.;
Kol, S.;
Benadiva, C.;
Engmann, L.;
Papanikolaou, E.G.

Publication type:

Article

Increased live birth rates with GnRH agonist addition for luteal support in ICSI/IVF cycles: a systematic review and meta-analysis.

Published in:

Human Reproduction Update, 2011, v. 17, n. 6, p. 734, doi. 10.1093/humupd/dmr029

By:

Kyrou, D.;
Kolibianakis, E.M.;
Fatemi, H.M.;
Tarlatzi, T.B.;
Devroey, P.;
Tarlatzis, B.C.

Publication type:

Article

GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data.

Published in:

Human Reproduction Update, 2012, v. 18, n. 2, p. 228, doi. 10.1093/humupd/dmr055

By:

Kolibianakis, E.M.;
Griesinger, G.;
Venetis, C.A.

Publication type:

Article

GnRH antagonists are safer than agonists: an update of a Cochrane review.

Published in:

Human Reproduction Update, 2011, v. 17, n. 4, p. 435, doi. 10.1093/humupd/dmr004

By:

Al-Inany, Hesham G.;
Youssef, Mohamed A.F.M.;
Aboulghar, Mohamed;
Broekmans, Frank;
Sterrenburg, Monique;
Smit, Janine;
Abou-Setta, Ahmed M.

Publication type:

Article

GnRH agonist for triggering of final oocyte maturation: time for a change of practice?

Published in:

Human Reproduction Update, 2011, v. 17, n. 4, p. 510

By:

Humaidan, P.;
Kol, S.;
Papanikolaou, EG.

Publication type:

Article

Interstitial pneumonitis secondary to leuprorelin acetate for prostate cancer.

Published in:

Respirology Case Reports, 2016, v. 4, n. 2, p. n/a, doi. 10.1002/rcr2.146

By:

Tan, Hsern Ern;
Lake, Fiona

Publication type:

Article

The addition of single dose GnRH agonist to luteal phase support in artificial cycle frozen embryo transfer: a randomized clinical trial.

Published in:

Gynecological Endocrinology, 2019, v. 35, n. 7, p. 618, doi. 10.1080/09513590.2018.1563888

By:

Ye, Hong;
Luo, Xiu;
Pei, Li;
Li, Fujie;
Li, Chunli;
Chen, Yueduo;
Zhang, Xiaodong;
Huang, Guoning

Publication type:

Article

Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF.

Published in:

Gynecological Endocrinology, 2017, v. 33, p. 18, doi. 10.1080/09513590.2017.1415676

By:

Muller, Valeria;
Kogan, Igor;
Yarmolinskaya, Maria;
Niauri, Dariko;
Gzgzyan, Alexandr;
Aylamazyan, Edward

Publication type:

Article

Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas.

Published in:

Gynecological Endocrinology, 2016, v. 32, n. 8, p. 646, doi. 10.3109/09513590.2016.1147547

By:

Adachi, Kazushige;
Takahashi, Kayo;
Nakamura, Koji;
Otake, Akiko;
Sasamoto, Naoko;
Miyoshi, Yukari;
Shioji, Mitsunori;
Yamamoto, Yoshimitsu;
Fujitani, Mayumi;
Wakimoto, Akinori;
Tokuhira, Atsushi;
Kobayashi, Eiji;
Yoshimura, Akihiko;
Sawada, Kenjiro;
Kimura, Tadashi

Publication type:

Article

The criteria for optimal down-regulation with gonadotropin-releasing hormone-agonist: a retrospective cohort study.

Published in:

Gynecological Endocrinology, 2015, v. 31, n. 12, p. 959, doi. 10.3109/09513590.2015.1101437

By:

Zheng, Yu;
Dong, Xiyuan;
Wang, Rui;
Yang, Wei;
Zhang, Hanwang;
Zhu, Guijin;
Ai, Jihui

Publication type:

Article